Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression
CuraFi aims to emerge as a critical ally in this scenario, assisting in managing drug spend efficiently, ensuring that the right patients have unimpeded access to Semaglutide without inflating costs
April 29, 2026 January 29, 2026 January 27, 2026 January 18, 2026 January 14, 2026 December 21, 2025 December 16, 2025 December 12, 2025 November 18, 2025 November 12, 2025 November 10, 2025 November 6, 2025 November 1, 2025 October 31, 2025 October 29, 2025 October 24, 2025 October 19, 2025 October 13, 2025 October 11, 2025 September 30, 2025 September 29, 2025 September 26, 2025 September 23, 2025 September 17, 2025 September 10, 2025 September 10, 2025 September 10, 2025 September 10, 2025 September 3, 2025 August 25, 2025 August 22, 2025 July 22, 2025 July 8, 2025 May 14, 2025
This publicly available database lists all patents and regulatory exclusivities for approved drugs, providing a roadmap for potential generic entrants
Considering the emerging link between impaired cerebellar function and mania, and that decreased serum BDNF is a biomarker of bipolar disorder, the decrease in cerebellar BDNF expression in the Camkk2 and Camk4 null mice suggests that defects in CaMKK2-CaMK4 signalling within the cerebellum may be involved in triggering manic behaviour [46,47,48,49]
